In the thymus, T cells are selected according to their T cell receptor (TCR) specificity. After positive selection, mature cells are exported from primary lymphoid organs to seed the secondary lymphoid tissue. An important question is whether survival of mature T cells is an intrinsic property or requires continuous survival signals, i.e., engagement of the TCR by major histocompatibility complex (MHC) molecules in the periphery, perhaps in a similar way as occurring during thymic positive selection. To address this issue we used recombination-activating gene (Rag)-deficient H-2b mice expressing a transgenic TCR restricted by I-Ed class II MHC molecules. After engraftment with Rag−/− H-2d fetal thymi, CD4+8− peripheral T cells emerged. These cells were isolated and transferred into immunodeficient hosts of H-2b or H-2d haplotype, some of the latter being common cytokine receptor γ chain deficient to exclude rejection of H-2b donor cells by host natural killer cells. Our results show that in the absence, but not in the presence, of selecting MHC molecules, peripheral mature T cells are short lived and disappear within 7 wk, indicating that continuous contact of the TCR with selecting MHC molecules is required for survival of T cells.
Positive selection of T cells in the thymus requires the interaction of the TCR on immature thymocytes with self-MHC molecules expressed on thymic epithelial cells (1–3). This process is dependent on the continual interaction of TCRs to MHC molecules since the transfer of thymocytes exhibiting only the first signs of positive selection (i.e., TCR upregulation and CD69 expression) into hosts lacking appropriate MHC molecule expression results in the loss of the transferred cells (4, 5). The presence of certain intermediate stages of T cell development in different gene-deficient mice also indicated that T cells were selected by a multistep process (6–8). Nevertheless, T cells do acquire functional maturity within the thymus since they can be stimulated to divide (9–11), as was found for recent thymic emigrants (12).
After the export to secondary lymphoid organs, some naive T cells do not divide but are long lived with an intermitotic lifespan of the order of 8 wk in euthymic mice, and much longer in athymic mice (13, 14). These experiments were performed in mice expressing the same MHC molecules in peripheral lymphoid tissue that induced positive selection in the thymus. Recently, some evidence was presented that MHC molecules in the peripheral lymphoid organs may have a role in sustaining long-term survival of mature T cells (15). We have addressed the same question in a different experimental system and, even though we agree that MHC molecules do support the survival of mature T cells, we have obtained results that differ from those obtained in the previous report (15). In our experiments, we have grafted recombination activating gene (Rag)1-deficient mice of H-2b haplotype that express a transgenic I-Ed-restricted TCR with thymi from fetal H-2d Rag−/− mice. This allowed the positive selection of CD4+8− T cells expressing the transgenic TCR. These cells were transferred into immunodeficient hosts of either H-2b or H-2d haplotype, some of the latter being deficient in expression of the common cytokine receptor γ chain (IL-2Rγ−/−) and therefore devoid of NK cells (16, 17). The results show that H-2d-restricting MHC molecules are required for survival of the transferred T cells in secondary lymphoid tissue.
Materials And Methods
BALB/c and BALB/c nu/nu mice were from IFFA-Credo (Orléans, France). BLACK nu/nu mice were from Bomholtgart (Ry, Denmark) and screened for H-2b homozygosity. Rag-2– (18) and Rag-1– (19) deficient mice were H-2b homozygous. Hemagglutinin-specific TCR transgenic mice (ABII TCR) on Rag-2−/− background have been described (8, 20). H-2d Rag-2−/− mice were obtained from Drs. Antonius Rolink and Shunichi Takeda (Basel Institute for Immunology, Basel, Switzerland; reference 15). These mice were crossed with IL-2Rγ−/− mice to obtain H-2d Rag-2−/− IL-2Rγ−/− mice. All breeding was done in the animal colonies at the Basel Institute for Immunology (Basel, Switzerland) and at the Netherlands Cancer Institute (Amsterdam, The Netherlands).
B Cell Depletion, Cell Sorting, and FACS Analysis.
Single cell suspensions of thymus, lymph nodes, and/or spleen (RBCs lysed or removed by Ficoll density gradient centrifugation) were prepared in PBS with 2% FCS. Where applicable, surface immunoglobulin-positive (sIg+) cells were depleted using Dynabeads (Milan, Switzerland).
6.5 (anti-ABII-TCR; reference 8) and MKD6 (anti-I-Aβd; reference 21) mAbs were labeled with FLUOS (Boehringer Mannheim, Mannheim, Germany). Heat stable antigen (HSA)-specific mAbs M1/69 (22) were biotinylated. FITC-labeled 104.2.1 mAbs (anti-Ly-5b; reference 23) were a gift of Dr. Hans-Reimer Rodewald (Basel Institute for Immunology, Basel, Switzerland). Anti-CD4-PE, anti-CD8-Red613 (GIBCO BRL, Gaithersburg, MD), and streptavidin-allophycocyanin (Molecular Probes Inc., Eugene, OR) conjugates were obtained commercially.
Cells were stained with mAbs at optimal dilution as determined before. Three and four-color flow cytometry was performed on FACStar+® or FACS-Vantage® (Becton Dickinson, Mountain View, CA) instruments.
Data (up to 5 × 105 events) were stored in list mode and analyzed with Lysys II or CellQuest software (Becton Dickinson). Dead cells were excluded using forward- and side-scatter parameters. Data are presented as dot plots with numbers in quadrants or regions indicating the proportion of cells within that area. Data from lymph nodes or spleen gave similar results whenever analyzed.
The recovery of transferred cells was calculated from the absolute number of cells recovered from spleen plus two times the number of cells recovered from lymph nodes each multiplied by the percentage of cells within the region of interest as determined by FACS® analysis. In case of staining before and after depletion of sIg+ cells, the average of both determinations, taking into account sIg+ cell depletion, was used for calculation. Note that from the experience of others, the recovery of lymphocytes immediately after transfer is estimated to be ∼20% after intravenous transfer (14, 24).
Lymphocyte Proliferation Assay.
Cell sorter purified responder cells were cultured with 5 × 105 X-irradiated (2,200 rad) stimulator cells in 200 μl Iscove's modified Dulbecco's medium supplemented with FCS (10%), β-mercaptoethanol (5 × 10−5 M), penicillin (100 IU/ml), and streptomycin (100 mg/ml). To some cultures, peptide 107-119 of influenza hemagglutinin (SVSSFERFEIFPK) was added at a final concentration of 5 μM. Cultures were kept in a water-saturated atmosphere of 6% CO2 in air at 37°C. After 48–60 h, 1 μCi [3H]thymidine (Amersham Corp., Arlington Heights, IL) was added and cells were cultured for a further 12–24 h when they were harvested. Incorporated radioactivity was measured by standard liquid scintillation counting.
Fetal Thymus Transplantation and Adoptive Transfers.
Fetal H-2d Rag-2−/− thymi were isolated at days 14–16 of gestation (plug day = day 0). For some experiments (Fig. 1), thymus lobes were isolated from BALB/c mice and cultured 5 d in medium containing 1.35 mM 2′-deoxyguanosine (dGuo; Sigma Chemical Co., St. Louis, MO). 1–2 lobes were transplanted under the kidney capsule of H-2b or H-2b/d ABII TCR Rag-2−/− mice. 6–16 wk later, cells were isolated from lymph nodes and spleen, stained with CD4, CD8, and I-Aβd-specific mAbs, and cell sorter purified. CD4+8− I-Aβd− and CD4−8low/+I-Aβd− cells were injected intravenously into various 4–6-wk-old recipient mice.
H-2d-restricted CD4+8− T Cells in Thymus Grafted ABII TCR Rag−/− H-2b Mice.
In our studies, we used ABII TCR transgenic mice that express a transgenic TCR specific for peptide 111-119 of influenza hemagglutinin presented by I-Ed class II MHC molecules. These mice were crossed onto the Rag−/− background to exclude the interference of TCRs with unknown specificity due to lack of allelic exclusion of the TCR-α locus (25, 26). To obtain T cells that are selected in the thymus but not able to encounter the selecting MHC molecules in peripheral lymphoid tissue, we transplanted H-2b ABII TCR Rag−/− mice with fetal thymi of H-2d haplotype that had been depleted of hematopoietic cells or were from Rag−/− background. (It is possible that some donor thymus-derived I-Ed–expressing cells emigrate from the graft. This will be addressed below.) Under such conditions, the thymus graft is seeded by T cell precursors of the host such that mature CD4+8− T cells with the transgenic TCR develop in the grafted H-2d, but not the host H-2b thymus (Fig. 1). Subsequently, CD4+8− T cells from the grafted thymus are exported to the periphery (Fig. 2). Such CD4+8− peripheral T cells are not present in H-2b ABII TCR Rag−/− mice, since cells with the I-Ed-restricted ABII TCR cannot develop in a H-2b thymus (8). There are also CD4−8low T cells in these mice that will be discussed below.
To confirm that the CD4+8− T cells in grafted mice were functionally mature, cells from such mice as well as from H-2d ABII TCR Rag−/− mice were isolated and stimulated with antigen presented by H-2d APCs. As shown in Table 1, both populations of cells gave proliferative responses that were in the same order of magnitude, indicating that they had acquired functional competence.
There was, however, a clear difference in the absolute number of CD4+8− T cells in the thymus-grafted H-2b ABII TCR Rag−/− mice and the H-2d ABII TCR Rag−/− mice in that the former contained far fewer cells than the latter (2.9 × 106; n = 3); and ranging between 107 to 108, respectively). This difference could be due to the fact that fewer CD4+8− T cells are produced/exported from the grafted thymus and/or the fact that the lack of I-Ed class II MHC molecules in the peripheral lymphoid organs of grafted H-2b ABII TCR Rag−/− mice resulted in a shorter life span of these cells. Further, the few CD4+8− T cells might be continuously renewed and/or depend on few I-Ed–expressing cells originating from the fetal thymus graft. To address the issue of whether peripheral expression of MHC molecules the CD4+8− T cells were selected on in the thymus was required for their peripheral survival, we performed transfer experiments into immunodeficient hosts expressing different MHC molecules.
CD4+8− Peripheral T Cells from H-2d Thymus-Grafted H-2b ABII TCR Rag−/− Mice Disappear in H-2b but Not in H-2d Adoptive Hosts.
We have shown previously that CD4−8low cells with the transgenic ABII TCR are an abundant subset in peripheral lymphoid organs of H-2b ABII TCR Rag−/− mice and therefore do not need I-Ed MHC molecules for selection and survival (8). This population most likely results from the unusual early expression of the α/β-TCR in TCR transgenic mice leading to the formation of γ/δ lineage T cells that express the transgenic α/β-TCR on the cell surface as discussed by Bruno et al. (27). Here, this subset serves as a convenient internal control to determine engraftment.
Cell sorter–purified CD4+8− and CD4−8low cells from thymus-grafted H-2b ABII TCR Rag−/− mice were transferred into either H-2b or H-2d immunodeficient recipient mice. As shown in Fig. 3, no 6.5+CD4+8− cells could be detected in either H-2b nu/nu or H-2d nu/nu recipient mice 7 wk after transfer, whereas 6.5+CD4−8low cells were found in the H-2b but not H-2d recipients. (Similar results were obtained after transfer into H-2b Rag−/− or H-2d Rag−/− recipient mice, data not shown.) In terms of engraftment, this result would be compatible with the notion that the transferred cells expressing H-2b MHC molecules only, could engraft in H-2b hosts, but not in H-2d hosts because of rejection by host NK cells (28–30). To circumvent this problem, a similar transfer of cells from thymus-grafted H-2b ABII TCR Rag−/− mice was performed into H-2b Rag−/− and H-2d Rag−/− IL-2Rγ−/− mice, devoid of NK cells (16, 17). As shown in Fig. 4, 6.5+CD4+8− cells survived only in H-2d recipients, whereas 6.5+CD4−8low cells survived both in H-2b and H-2d recipients when analyzed 7 wk after transfer. Taken together, these results show that in H-2b recipients, NK cells do not reject the transferred cells as 6.5+CD4−8low cells survive, but 6.5+CD4+8− cells vanish due to the lack of H-2d MHC molecules. In contrast, 6.5+CD4+8− cells survive long term in the presence of H-2d MHC molecules once not rejected by NK cells. 6.5+CD4−8low cells survived then as well.
In other experiments, we have followed the fate of CD4+8− and CD4−8low cells from thymus-grafted H-2b/d ABII TCR Rag−/− mice upon transfer into either H-2b or H-2d immunodeficient recipient mice. (The H-2b/d ABII TCR Rag−/− mice themselves cannot select the ABII TCR in the thymus due to preferential pairing of Eα with Eβb chains; references 8, 31, 32.) 3 d after transfer, both populations were present in H-2b nu/nu and H-2d nu/nu recipients. 7 wk later, both subsets were present in H-2d nu/nu recipients but could no longer be found in H-2b nu/nu recipients (data not shown, made available to reviewers). This might indicate that the shared class I MHC molecule expression between H-2b/d hybrid donor and homozygous host protected the donor cells from NK cell– mediated lysis in H-2d homozygous hosts, but that the reduced class I H-2b MHC molecule expression of H-2b/d hybrid cells was not sufficient to circumvent NK cell–mediated lysis in H-2b homozygous hosts. Such differences might become evident only upon transfer of relatively small numbers of cells as performed here. An inverse correlation between the level of class I expression and NK cell lysis has indeed been observed (33), and NK cell–mediated lysis of hybrid cells did not always occur to the same extent in each of the parental strains (34). Further, H-2b cells expressing transgene-encoded Dd MHC class I molecules were rejected by NK cells in otherwise syngenic H-2b hosts (35).
Our data show that appropriate MHC molecules are required to support the survival of mature α/β T cells in peripheral lymphoid tissue; a conclusion in line with previously published experiments (15). In the latter study, however, polyclonal CD4+8− T cells in thymus-grafted Rag class II MHC double deficient mice appeared to survive much longer since significant numbers of cells could still be found 16 wk after export from the thymus ceased. This may be due to the fact that in these experiments, CD4+8− T cells with class I MHC–restricted TCRs (36–38) could interact with class I MHC molecules expressed in the peripheral lymphoid tissue or due to the fact that some class II MHC–positive cells had migrated from the transplanted thymus into the periphery. In both of these cases, T cells could have been stimulated by antigen. The high proportion of proliferating CD4+8− T cells at various points in time after thymus transfer could indicate that this was indeed the case, and some CD4+8− T cells might have rather disappeared because of exhaustion (39, 40). These possibilities were excluded in our experiments; the CD4+8− T cells were of known antigen specificity and MHC restriction. Any potential class II MHC molecule–expressing cells originating from the thymus graft were removed by cell sorting before transfer into adoptive recipients.
In line with our previous observations, we noticed expansion of CD4+8− ABII TCR-expressing cells in H-2d mice (reference 41 and this report). Currently, it is not clear whether T cell survival in the absence (13, 14) or the presence (41) of proliferation (or both possibilities) reflects the normal physiologic situation. Interestingly, normal mice that had been thymectomized have some cells of naive phenotype that label with BrdU (42).
Irrespective of the MHC environment, CD4−8low cells that are not dependent on positive selection in the thymus, did expand after transfer. Presently, the biology of these cells is not well understood and it has been speculated that these cells represent γ/δ lineage T cells expressing the transgenic α/β-TCR (27).
While it becomes established that T cells require the interaction of their TCRs with selecting MHC molecules for survival in the peripheral lymphoid tissue, the mechanism behind this requirement is unknown. In the thymus, immature CD4+8− cells express low levels of the cell death– repressing bcl-2 protein. They have a half life of 3 d (43) unless their TCR binds with sufficient affinity to self-MHC molecules resulting in maturation that is accompanied by bcl-2 upregulation (44–47). One might then speculate that the level of bcl-2 expression and, hence, survival is (indirectly) regulated by TCR ligation with selecting MHC molecules in the absence of antigen. In that respect, peripheral survival could be similar to thymic positive selection. The data reported on T cells from bcl-2–deficient mice are compatible with such a hypothesis (48–51). We have investigated bcl-2 expression by intracellular staining of CD4+8− cells from thymus-grafted H-2b ABII TCR Rag−/− and H-2d ABII TCR Rag−/− mice. However, the differences we observed were far less dramatic than during thymic positive selection (mean fluorescence reduced to 74 compared to 98 in controls, whereas in the thymus, a threefold difference was detectable: 44 versus 120 in an independent experiment). This could be due to the fact that cells with low bcl-2 expression are rapidly dying and eliminated and escape detection.
Further, it will be of interest to determine whether TCR contact with selecting MHC molecules on any type of cell is sufficient for T cell survival or whether the selecting MHC molecules have to be encountered on a specific cell type. The latter would be analogous to the requirement of TCR–MHC molecule interaction on thymic epithelial cells for thymic positive selection (3). Interestingly, RelB-deficient mice that lack dendritic cells have an increased proportion of activated T cells, whereas absolute numbers of T cells are reduced (52, 53). The former might be due to limited self-censorship in the thymus followed by peripheral activation by self-antigens the T cells were not tolerized for in the thymus (52–55). The latter, however, could indicate that (naive) peripheral T cell survival requires TCR interaction with selecting MHC molecules on dendritic cells. The data of DeKoning et al. on transfer of naive TCR transgenic T cells into RelB−/− mice support this theory (53).
We thank M. Dessing, S. Meyer, and E. Noteboom for expert help with flow cytometry and cell sorting; the animal care takers (especially E. Wagner and W. Metzger, and L. Tolkamp in Basel, Switzerland and Amsterdam, The Netherlands, respectively) for making possible these experiments; H.-P. Stahlberger for art work; P. Krimpenfort for providing the IL-2Rγ−/− mice; and John D. Allen, Thomas Brocker, and Hergen Spits for reading the manuscript. The TCR clonotype specific mAb 6.5 was produced by B. Riwar and H. Kishi. The Basel Institute for Immunology was founded and is supported by F. Hoffmann-La Roche Ltd. (Basel, Switzerland). J. Kirberg receives a fellowship from the Boehringer Ingelheim Foundation (Stuttgart, Germany).
Abbreviations used in this paper: dGuo, 2′-deoxyguanosine; Rag, recombination activating gene; sIg, surface Ig; HSA, heat stable antigen.
Address correspondence to Jörg Kirberg, Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, NL-1066 CX Amsterdam, The Netherlands. Phone: 0031-20-512 19 98; FAX: 0031-20-512 20 11; E-mail: email@example.com